The <scp>HN1</scp> / <scp>HMGB1</scp> axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The HN1 / HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin

Published:2022-06-10 Issue:20 Volume:289 Page:6400-6419
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:The FEBS Journal

Author:

Wang Ruhua¹,Fu Yunong²,Yao Menglin¹,Cui Xiaomeng¹,Zhao Yan¹,Lu Xinlan¹,Li Yarui¹^ORCID,Lin Yiguang³,He Shuixiang¹^ORCID

Affiliation:

1. Department of Gastroenterology The First Affiliated Hospital of Xi'an Jiaotong University China

2. Department of Hepatobiliary Surgery The First Affiliated Hospital of Xi'an Jiaotong University China

3. School of Life Sciences University of Technology Sydney Broadway NSW Australia

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.16531

Reference63 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma

3. Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia

4. FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma

5. Stem cell fate in cancer growth, progression and therapy resistance

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HN1-mediated activation of lipogenesis through Akt-SREBP signaling promotes hepatocellular carcinoma cell proliferation and metastasis;Cancer Gene Therapy;2024-09-09

2. Role of hematological and neurological expressed 1 (HN1) in human cancers;Critical Reviews in Oncology/Hematology;2024-09

3. TRIM28 in cancer and cancer therapy;Frontiers in Genetics;2024-07-19

4. Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-05

5. HN1 is a novel dedifferentiation factor involved in regulating the cell cycle and microtubules in SH‐SY5Y neuroblastoma cells;Journal of Cellular Biochemistry;2024-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3